Progression of human cutaneous melanoma is associated with loss of expression of c‐kit proto‐oncogene receptor

International Journal of Cancer

Volumn 52, Issue 2, 1992, Pages 197-201

  Natali, P G ^a   Nicotra, M R ^b   Winkler, A B ^c   Cavaliere, R ^a   Bigotti, A ^a   Ullrich, A ^c  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b CNR   (Italy)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RECEPTOR;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; PROTO ONCOGENE; SKIN CANCER; TUMOR GROWTH; TUMOR PROMOTION;

ANTIBODIES, MONOCLONAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN; MELANOCYTES; MELANOMA; PROTO-ONCOGENE PROTEIN C-KIT; PROTO-ONCOGENE PROTEINS; RECEPTORS, CELL SURFACE; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T;

EID: 0026793058     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910520207     Document Type: Article

References (22)

1. Integrin distribution in malignant melanoma: association of the β3 sub‐Unit with tumor progression
2. Molecular themes in oncogenesis
3. Cross‐Sectional areas and depth of invasion in the prognosis of cutaneous melanoma
4. The product of the proto‐Pncogene c‐Kit is a human bone‐Marrow surface antigen of hemopoietic precursor cells which is expressed on a sub‐Set of acute non‐Lymphoblastic leukemic cells
5. Fibroblast cell interactions with human melanoma cells growth as a function of tumor progression
6. Transformation of melanocytes with basic fibroblast growth factor CDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment
7. HLA antigens on tumor cells
8. The dominant white spotting (w) locus of the mouse encodes the c‐Kit proto‐Oncogene
9. Recombinant human IFN‐γ, but not IFN‐α or IFN‐β, enhances MHC‐ and non‐MHC‐Encoded glycoprotein by a protein‐Synthesis‐Dependent mechanism
10. Primary melanoma cells of the vertical growth phase: similarities to metastatic cells
11. Tumor progression in human malignant melanoma: five stages defined by their antigenic pheno types
12. The hematopoietic growth factor KL is encoded by the S/Locus and is the ligand of the c‐Kit receptor, the gene product of the w locus
13. Presence of cytoadhesines (iI b‐IIIa‐Like glygoproteins on human metastatic melanoma but not on benign melanocytes
14. Expression and production of tenascin in benign and malignant lesions or melanocyte lineage
15. Differential expression of intercellular adhesion molecule I in primary and metastatic melanoma lesions
16. Tumor progression in human malignant melanoma is associated with changes in α6/β1 laminin receptor
17. In utero manipulation of coat‐Color formation by a monoclonal anti‐C‐Kit antibody: two distinct waves of c‐kit‐Dependency during melanocyte development
18. Relation of cytogenetic abnormalities and clinical outcome in metastatic melanoma
19. Immunochemical analysis of the antigenic profile of human melanoma cells with monoclonal antibodies
20. Human proto‐Oncogene c‐Kit, a new cell‐Surface‐Receptor tyrosine kinase for an unidentified ligand